Home
Conditions
Lipid Metabolism, Inborn Errors

Clinical trial condition

Lipid Metabolism, Inborn Errors

Explore clinical trials studying Lipid Metabolism, Inborn Errors. Study availability and eligibility vary by location and protocol.

841 public trials 150 recruiting studies

Refine in advanced search Browse all conditions

Lipid Metabolism, Inborn Errors trial results

Completed

The Fabrazyme® and Arbs and ACE Inhibitor Treatment (FAACET) Study

NCT00446862

Conditions: Brain Diseases, Brain Diseases, Metabolic, Brain Diseases, Metabolic, Inborn, +29 more
Locations: University of Alabama at Birmingham Birmingham, Alabama, United States

Emory University Atlanta, Georgia, United States

Feinberg School of Medicine, Northwestern University Chicago, Illinois, United States

University of Iowa Iowa City, Iowa, United States

View Trial Details

Completed

Short-term Effect of Extended-release Niacin on Endothelial Function.

NCT01942291

Conditions: Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Dyslipidemias, Genetic Diseases, Inborn, +8 more
Locations: University of Campinas Campinas, São Paulo, Brazil

View Trial Details

Completed

Effect of High Protein Diet on Cardiovascular Diseases Risk Factors Among Overweight and Obese Children

NCT01886482

Conditions: Body Mass Index Quantitative Trait Locus 7 Disorder, Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Dyslipidemias, +13 more
Locations: Isfahan University of Medical Sciences Isfahan, Iran

View Trial Details

Completed

Effect of High Protein Diet on Adiponectin and Inflammation Among Overweight and Obese Children

NCT01886495

Conditions: Body Mass Index Quantitative Trait Locus 5 Disorder, Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Dyslipidemias, +13 more
Locations: Isfahan University of Medical Sciences Leila Azadbakht, Phd Isfahan, Iran

View Trial Details

Completed

Bioequivalence Study of Metoprolol Succinate Extended Release Tablets 200 mg Under Fed Conditions

NCT01884909

Conditions: Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Dyslipidemias, Fed, +9 more
Locations: Cliantha Research Limited Ahmedabad, Gujarat, India

View Trial Details

Completed

A Study of the Tolerability, Safety, and Pharmacokinetics of ISU302 in Healthy Volunteers

NCT01881633

Conditions: Brain Diseases, Brain Diseases, Metabolic, Brain Diseases, Metabolic, Inborn, +14 more
Locations: Not specified

View Trial Details

Completed

Biomarker Validation for Niemann-Pick Disease, Type C: Safety and Efficacy of N-Acetyl Cysteine

NCT00975689

Conditions: Brain Diseases, Brain Diseases, Metabolic, Brain Diseases, Metabolic, Inborn, +22 more
Locations: National Institutes of Health Clinical Center, 9000 Rockville Pike Bethesda, Maryland, United States

View Trial Details

Completed

Bioequivalence Study of Lisinopril and Hydrochlorothiazide Tablets (20+25) mg Under Fed Conditions

NCT01827878

Conditions: Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Dyslipidemias, Fed, +9 more
Locations: Accutest Research Lab (I) Pvt. Ltd. Ahmedabad, Gujarat, India

View Trial Details

Completed

Safety, Tolerability and Efficacy of Microsomal Triglyceride Protein (MTP) Inhibitor

NCT01556906

Conditions: Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Dyslipidemias, Genetic Diseases, Inborn, +9 more
Locations: University of Pennsylvania Philadelphia, Pennsylvania, United States

View Trial Details

Completed

Tomato Consumption and High Density Lipoprotein-cholesterol

NCT01342666

Conditions: Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Dyslipidemias, Genetic Diseases, Inborn, +8 more
Locations: Instituto Nacional de Ciencias Medicas y Nutricion Salvador Zubiran México, Tlalpan, Mexico

View Trial Details

Lipid Metabolism, Inborn Errors

Lipid Metabolism, Inborn Errors trial results

Related conditions